Skip to main content

Heart attacks deaths halved in the last decade, experts say

The death rate from heart attacks in England has halved in the last decade, says an Oxford University study.
The research, published in the British Medical Journal, looked at more than 800,000 men and women who suffered heart attacks between 2002 and 2010.
They found that fewer heart attacks occurred in later years and, of those that did occur, fewer were fatal.
Researchers say improvements in NHS care and better prevention measures have contributed to the decline.
The Oxford researchers used national hospital and mortality data to analyse 840,175 men and women in England who had suffered a total of 861,134 heart attacks over eight years.
Comparing 2002 with 2010, they found death rates falling by 50% in men (78.7 per 100,000 population to 39.2) and by 53% in women (37.3 per 100,000 to 17.7).
A declining mortality rate was also seen in all age groups and for both sexes.

Focus on youngest
The research on bmj.com concluded that just over half of the decline in deaths can be attributed to a decline in the number of new heart attacks, and just under half to a decline in the death rate after a heart attack.
But the greatest rates of decline occurred in men and women aged 65-74 and the lowest in those aged 30-54 and 85 and older.
The study said that rising rates of obesity and diabetes could explain the lack of improvement in the occurrence of heart attacks among the youngest age group.
The factors behind the decrease in heart attack death rate differed by age, sex and geographical area.
The research authors said that further research is needed to gain a clearer understanding of the specific elements of prevention and treatment that have led to the fall in death rates.
And Prof Peter Weissberg, medical director at the British Heart Foundation, said there was still more to do to cut unnecessary deaths.
"This impressive fall in death rates is due partly to prevention of heart attacks by better management of risk factors such as smoking, high blood pressure and cholesterol and due partly to better treatment of heart attack patients when they reach hospital.
"But far too many heart attack victims still die from a cardiac arrest before medical help arrives. Many of these deaths could be prevented by rapid cardiopulmonary resuscitation."
Heart attacks graph 

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such
Post a Comment
Read more

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volume delivered to
Post a Comment
Read more

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n
4 comments
Read more